Clinical trial
Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in…
NCT00135031 · Procter and Gamble, Industry · Completed
Key facts
| NCT number | NCT00135031 |
|---|---|
| Title | Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Safety and Efficacy Evaluation of Bifidobacterium Infantis 35624 in Female Subjects With Irritable Bowel Syndrome |
| Lead sponsor | Procter and Gamble, Industry |
| Collaborators | Alimentary Health Ltd Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | Bifidobacterium infantis 35624 |
| Enrollment | 362 |
| Start date | Jan 1, 2004 |
| Primary completion | Sep 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Aug 25, 2005 |
| Last update posted | Jun 15, 2011 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: